Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 4.10 Billion

CAGR (2025-2030)

8.00%

Fastest Growing Segment

Poultry

Largest Market

North America

Market Size (2030)

USD 6.51 Billion

Market Overview

The Global Animal Intestinal Health Market will grow from USD 4.10 Billion in 2024 to USD 6.51 Billion by 2030 at a 8.00% CAGR. The global animal intestinal health market comprises products and solutions designed to support and optimize the gastrointestinal well-being of both livestock and companion animals. These offerings, which include probiotics, prebiotics, enzymes, and phytogenics, are essential for maintaining microbial balance, enhancing nutrient absorption, and bolstering immune function. Key drivers propelling this market include the escalating global demand for animal protein, driven by population growth and rising incomes, alongside increasing awareness of animal welfare and the critical role of gut health in overall animal performance. The industry is also significantly influenced by global efforts to reduce antibiotic use in animal agriculture, which necessitates effective alternative health-promoting feed additives.

Regarding market scope, according to the 2025 Alltech Agri-Food Outlook, global compound feed production reached 1.396 billion metric tons in 2024, reflecting a 1.2% increase from the previous year, thereby highlighting the expanding foundational demand for animal nutrition products. However, a significant challenge impeding market expansion is the presence of stringent and inconsistent regulatory frameworks across diverse geographical regions, which can complicate product development and market entry.

Key Market Drivers

The sustained increase in the global demand for animal protein stands as a primary catalyst for the animal intestinal health market. As populations grow and incomes rise, the imperative to maximize livestock productivity and minimize losses from disease becomes paramount, driving the adoption of solutions that bolster animal gut health. According to the OECD-FAO Agricultural Outlook 2025-2034, published in July 2025, global meat production rose by an estimated 1.3% in 2024, reaching 365 million tons. This consistent upward trajectory in protein demand directly translates into a heightened requirement for advanced nutritional and health interventions within animal agriculture.

Concurrently, a significant market driver is the pervasive shift towards natural and antibiotic-free growth promoters, largely propelled by escalating concerns over antimicrobial resistance and evolving consumer preferences. This movement necessitates the widespread implementation of alternative strategies to maintain animal health and growth performance. For instance, according to a multi-agency analysis by the European Centre for Disease Prevention and Control, the European Food Safety Authority, and the European Medicines Agency, published in February 2024, antibiotic consumption in food-producing animals in Europe decreased by 44% between 2014 and 2021. The demand for such interventions is further underscored by the substantial economic footprint of livestock, a sector where intestinal health solutions directly contribute to overall animal well-being. According to Investec's Global Animal Health 2025 Insight Report, published in September 2025, the livestock segment represents 60% of the total animal health market value.


Download Free Sample Report

Key Market Challenges

Stringent and inconsistent regulatory frameworks across diverse geographical regions present a significant impediment to the growth of the global animal intestinal health market. These varied and often complex regulations create substantial hurdles for product development and market entry, demanding extensive investment in research, testing, and documentation to meet disparate compliance standards. Such requirements not only inflate operational costs but also prolong the timelines for introducing new, health-promoting products to the market.

The lack of harmonization among different jurisdictions further complicates market expansion strategies for manufacturers, hindering their ability to scale operations efficiently. According to the U.S. Food and Drug Administration, in Fiscal Year 2024, the fee for an animal drug application was $683,673. These substantial financial commitments, coupled with the extended approval processes, directly inhibit innovation and deter companies from investing in developing novel intestinal health solutions. This regulatory burden ultimately slows the pace at which beneficial products can reach livestock and companion animals, thereby directly impeding the overall expansion of the market.

Key Market Trends

The global animal intestinal health market is significantly influenced by a trend toward advanced gut microbiome modulation strategies. This involves a shift from conventional broad-spectrum additives to more targeted and sophisticated interventions designed to precisely influence the animal gut environment. These strategies encompass the development of highly specific probiotic strains, advanced enzyme technologies, and other biological approaches that aim for a deeper level of microbial control to enhance animal health and productivity. The European Feed Manufacturers' Federation (FEFAC), at its Annual Public Meeting in 2024, highlighted the urgent need for the European Union to accelerate support for innovative technologies in feed additives, underscoring the industry's drive toward such advancements. For instance, Novonesis, a company formed in 2024, expanded its poultry feed enzyme portfolio in October 2025, announcing plans to integrate enzymes and probiotics to improve poultry performance and welfare.

Another pivotal trend driving the market is the expansion of companion animal gut health product offerings. This trend is fueled by the growing humanization of pets and owners' increased willingness to invest in their pets' well-being, leading to a demand for specialized nutritional solutions. Pet owners are adopting a more proactive stance toward preventative healthcare for their companion animals. According to the American Pet Products Association (APPA), total U.S. pet industry expenditures reached $152 billion in 2024, with pet food and treats accounting for $65.8 billion, demonstrating the substantial and growing financial commitment to pet care. Reflecting this, Hill's Pet Nutrition, in November 2025, unveiled new Prescription Diet Digestive Care foods specifically formulated for puppies and kittens, featuring a proprietary blend of prebiotics clinically proven to support the gut microbiome.

Segmental Insights

The poultry segment is emerging as the fastest-growing sector within the global animal intestinal health market, driven primarily by escalating consumer demand for affordable animal protein globally. This robust growth necessitates optimized feed conversion and enhanced production efficiency in poultry farming. Furthermore, stringent regulatory pressures, exemplified by initiatives from bodies such as the European Union enforcing bans on antibiotic growth promoters, compel producers to adopt natural and sustainable gut health solutions. Consequently, the focus shifts towards additives like probiotics and prebiotics to prevent intestinal disorders, support immune function, and ensure overall flock well-being in an antibiotic-reduced environment.

Regional Insights

North America stands as the leading region in the global animal intestinal health market, driven by its sophisticated animal health infrastructure and advanced livestock production systems. The region benefits from strong regulatory frameworks and favorable policies that encourage the adoption of gut health products, notably influenced by a growing emphasis on reducing antibiotic growth promoters. Significant investments in research and development, coupled with a robust presence of major industry players and efficient distribution networks, further reinforce its market dominance. Additionally, high rates of pet adoption and substantial expenditure on animal health, alongside the United States' prominent role in global animal production, contribute to this leadership.

Recent Developments

  • In November 2025, Australian agricultural biotechnology company Terragen will commence its first international feedlot trial in Canada for Terragen's Probiotic™ for Ruminants (TPR). This research collaboration, involving leading Canadian research organizations, aims to evaluate the product's impact on cattle performance, carcass quality, and the crucial gut-immune connection within feedlot systems. TPR, a dry-form, shelf-stable probiotic, can be integrated into various feed types to support gastrointestinal health and productivity in beef and dairy cattle. This study seeks to validate the probiotic's value to producers and advance scientific understanding of its mechanisms of action.

  • In March 2025, Orffa and Florates introduced a new gut health diagnostic technology called "Instant Insight in Gut Health" at VIV Asia 2025. This pioneering tool provides rapid, data-driven insights into the intestinal health of livestock. Developed through a strategic partnership, the technology combines non-invasive sampling with predictive analytics, delivering comprehensive gut health reports within 24 hours. The collaboration aims to enable a shift from reactive treatments to proactive management in livestock, supporting optimized animal performance, welfare, and sustainability by providing timely insights into the gut microbiome, which is critical for reducing antibiotic reliance.

  • In November 2024, Evonik launched Ecobiol Soluble Plus in the Indian market at Poultry India 2024. This innovative water-soluble probiotic is designed to significantly enhance poultry production by improving gut health and overall animal performance. Formulated to support gut integrity and improve nutrient absorption, the product contains *Bacillus amyloliquefaciens* CECT 5940, a beneficial bacterium. This new solution addresses challenges such as heat stress and intestinal diseases prevalent in tropical climates, promoting optimal feed utilization and growth, thereby contributing to robust animal intestinal health and well-being.

  • In June 2024, Purina Animal Nutrition introduced a new live and active probiotic supplement and a microbiome testing kit for horses. These products, named Purina Systemiq Probiotic Supplement and Purina MQ Equine Microbiome Testing Kit, are part of the new Purina Microbiome Quotient (MQ) Platform. The platform empowers horse owners to receive personalized nutrition recommendations, thereby proactively optimizing their horse's gut health. This innovation in equine microbiome science supports optimal digestive and immune function, representing a significant advancement in tailored animal intestinal health solutions to enhance horse wellness and performance.

Key Market Players

  • AB Agri Limited
  • Cargill, Incorporated
  • Calpis Co., Ltd.
  • Chr. Hansen A/S
  • Dr. Eckel Animal Nutrition GmbH & Co. KG
  • Evonik Industries AG
  • Kemin Industries, Inc.
  • Koninklijke DSM N.V.
  • Lallemand Inc.

By Livestock

By Additive

By Form

By Source

By Region

  • Aquaculture
  • Poultry
  • Ruminant
  • Swine
  • Others
  • Probiotics
  • Prebiotics
  • Immunostimulants
  • Phytogenics
  • Dry
  • Liquid
  • Microbial
  • Plant Based
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
  • Report Scope:

    In this report, the Global Animal Intestinal Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

    • Animal Intestinal Health Market, By Livestock:

    o   Aquaculture

    o   Poultry

    o   Ruminant

    o   Swine

    o   Others

    • Animal Intestinal Health Market, By Additive:

    o   Probiotics

    o   Prebiotics

    o   Immunostimulants

    o   Phytogenics

    • Animal Intestinal Health Market, By Form:

    o   Dry

    o   Liquid

    • Animal Intestinal Health Market, By Source:

    o   Microbial

    o   Plant Based

    • Animal Intestinal Health Market, By Region:

    o   North America

    §  United States

    §  Canada

    §  Mexico

    o   Europe

    §  France

    §  United Kingdom

    §  Italy

    §  Germany

    §  Spain

    o   Asia Pacific

    §  China

    §  India

    §  Japan

    §  Australia

    §  South Korea

    o   South America

    §  Brazil

    §  Argentina

    §  Colombia

    o   Middle East & Africa

    §  South Africa

    §  Saudi Arabia

    §  UAE

    Competitive Landscape

    Company Profiles: Detailed analysis of the major companies presents in the Global Animal Intestinal Health Market.

    Available Customizations:

    Global Animal Intestinal Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to five).

    Global Animal Intestinal Health Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

    Table of content

    Table of content

    1.    Product Overview

    1.1.  Market Definition

    1.2.  Scope of the Market

    1.2.1.  Markets Covered

    1.2.2.  Years Considered for Study

    1.2.3.  Key Market Segmentations

    2.    Research Methodology

    2.1.  Objective of the Study

    2.2.  Baseline Methodology

    2.3.  Key Industry Partners

    2.4.  Major Association and Secondary Sources

    2.5.  Forecasting Methodology

    2.6.  Data Triangulation & Validation

    2.7.  Assumptions and Limitations

    3.    Executive Summary

    3.1.  Overview of the Market

    3.2.  Overview of Key Market Segmentations

    3.3.  Overview of Key Market Players

    3.4.  Overview of Key Regions/Countries

    3.5.  Overview of Market Drivers, Challenges, Trends

    4.    Voice of Customer

    5.    Global Animal Intestinal Health Market Outlook

    5.1.  Market Size & Forecast

    5.1.1.  By Value

    5.2.  Market Share & Forecast

    5.2.1.  By Livestock (Aquaculture, Poultry, Ruminant, Swine, Others)

    5.2.2.  By Additive (Probiotics, Prebiotics, Immunostimulants, Phytogenics)

    5.2.3.  By Form (Dry, Liquid)

    5.2.4.  By Source (Microbial, Plant Based)

    5.2.5.  By Region

    5.2.6.  By Company (2024)

    5.3.  Market Map

    6.    North America Animal Intestinal Health Market Outlook

    6.1.  Market Size & Forecast

    6.1.1.  By Value

    6.2.  Market Share & Forecast

    6.2.1.  By Livestock

    6.2.2.  By Additive

    6.2.3.  By Form

    6.2.4.  By Source

    6.2.5.  By Country

    6.3.    North America: Country Analysis

    6.3.1.    United States Animal Intestinal Health Market Outlook

    6.3.1.1.  Market Size & Forecast

    6.3.1.1.1.  By Value

    6.3.1.2.  Market Share & Forecast

    6.3.1.2.1.  By Livestock

    6.3.1.2.2.  By Additive

    6.3.1.2.3.  By Form

    6.3.1.2.4.  By Source

    6.3.2.    Canada Animal Intestinal Health Market Outlook

    6.3.2.1.  Market Size & Forecast

    6.3.2.1.1.  By Value

    6.3.2.2.  Market Share & Forecast

    6.3.2.2.1.  By Livestock

    6.3.2.2.2.  By Additive

    6.3.2.2.3.  By Form

    6.3.2.2.4.  By Source

    6.3.3.    Mexico Animal Intestinal Health Market Outlook

    6.3.3.1.  Market Size & Forecast

    6.3.3.1.1.  By Value

    6.3.3.2.  Market Share & Forecast

    6.3.3.2.1.  By Livestock

    6.3.3.2.2.  By Additive

    6.3.3.2.3.  By Form

    6.3.3.2.4.  By Source

    7.    Europe Animal Intestinal Health Market Outlook

    7.1.  Market Size & Forecast

    7.1.1.  By Value

    7.2.  Market Share & Forecast

    7.2.1.  By Livestock

    7.2.2.  By Additive

    7.2.3.  By Form

    7.2.4.  By Source

    7.2.5.  By Country

    7.3.    Europe: Country Analysis

    7.3.1.    Germany Animal Intestinal Health Market Outlook

    7.3.1.1.  Market Size & Forecast

    7.3.1.1.1.  By Value

    7.3.1.2.  Market Share & Forecast

    7.3.1.2.1.  By Livestock

    7.3.1.2.2.  By Additive

    7.3.1.2.3.  By Form

    7.3.1.2.4.  By Source

    7.3.2.    France Animal Intestinal Health Market Outlook

    7.3.2.1.  Market Size & Forecast

    7.3.2.1.1.  By Value

    7.3.2.2.  Market Share & Forecast

    7.3.2.2.1.  By Livestock

    7.3.2.2.2.  By Additive

    7.3.2.2.3.  By Form

    7.3.2.2.4.  By Source

    7.3.3.    United Kingdom Animal Intestinal Health Market Outlook

    7.3.3.1.  Market Size & Forecast

    7.3.3.1.1.  By Value

    7.3.3.2.  Market Share & Forecast

    7.3.3.2.1.  By Livestock

    7.3.3.2.2.  By Additive

    7.3.3.2.3.  By Form

    7.3.3.2.4.  By Source

    7.3.4.    Italy Animal Intestinal Health Market Outlook

    7.3.4.1.  Market Size & Forecast

    7.3.4.1.1.  By Value

    7.3.4.2.  Market Share & Forecast

    7.3.4.2.1.  By Livestock

    7.3.4.2.2.  By Additive

    7.3.4.2.3.  By Form

    7.3.4.2.4.  By Source

    7.3.5.    Spain Animal Intestinal Health Market Outlook

    7.3.5.1.  Market Size & Forecast

    7.3.5.1.1.  By Value

    7.3.5.2.  Market Share & Forecast

    7.3.5.2.1.  By Livestock

    7.3.5.2.2.  By Additive

    7.3.5.2.3.  By Form

    7.3.5.2.4.  By Source

    8.    Asia Pacific Animal Intestinal Health Market Outlook

    8.1.  Market Size & Forecast

    8.1.1.  By Value

    8.2.  Market Share & Forecast

    8.2.1.  By Livestock

    8.2.2.  By Additive

    8.2.3.  By Form

    8.2.4.  By Source

    8.2.5.  By Country

    8.3.    Asia Pacific: Country Analysis

    8.3.1.    China Animal Intestinal Health Market Outlook

    8.3.1.1.  Market Size & Forecast

    8.3.1.1.1.  By Value

    8.3.1.2.  Market Share & Forecast

    8.3.1.2.1.  By Livestock

    8.3.1.2.2.  By Additive

    8.3.1.2.3.  By Form

    8.3.1.2.4.  By Source

    8.3.2.    India Animal Intestinal Health Market Outlook

    8.3.2.1.  Market Size & Forecast

    8.3.2.1.1.  By Value

    8.3.2.2.  Market Share & Forecast

    8.3.2.2.1.  By Livestock

    8.3.2.2.2.  By Additive

    8.3.2.2.3.  By Form

    8.3.2.2.4.  By Source

    8.3.3.    Japan Animal Intestinal Health Market Outlook

    8.3.3.1.  Market Size & Forecast

    8.3.3.1.1.  By Value

    8.3.3.2.  Market Share & Forecast

    8.3.3.2.1.  By Livestock

    8.3.3.2.2.  By Additive

    8.3.3.2.3.  By Form

    8.3.3.2.4.  By Source

    8.3.4.    South Korea Animal Intestinal Health Market Outlook

    8.3.4.1.  Market Size & Forecast

    8.3.4.1.1.  By Value

    8.3.4.2.  Market Share & Forecast

    8.3.4.2.1.  By Livestock

    8.3.4.2.2.  By Additive

    8.3.4.2.3.  By Form

    8.3.4.2.4.  By Source

    8.3.5.    Australia Animal Intestinal Health Market Outlook

    8.3.5.1.  Market Size & Forecast

    8.3.5.1.1.  By Value

    8.3.5.2.  Market Share & Forecast

    8.3.5.2.1.  By Livestock

    8.3.5.2.2.  By Additive

    8.3.5.2.3.  By Form

    8.3.5.2.4.  By Source

    9.    Middle East & Africa Animal Intestinal Health Market Outlook

    9.1.  Market Size & Forecast

    9.1.1.  By Value

    9.2.  Market Share & Forecast

    9.2.1.  By Livestock

    9.2.2.  By Additive

    9.2.3.  By Form

    9.2.4.  By Source

    9.2.5.  By Country

    9.3.    Middle East & Africa: Country Analysis

    9.3.1.    Saudi Arabia Animal Intestinal Health Market Outlook

    9.3.1.1.  Market Size & Forecast

    9.3.1.1.1.  By Value

    9.3.1.2.  Market Share & Forecast

    9.3.1.2.1.  By Livestock

    9.3.1.2.2.  By Additive

    9.3.1.2.3.  By Form

    9.3.1.2.4.  By Source

    9.3.2.    UAE Animal Intestinal Health Market Outlook

    9.3.2.1.  Market Size & Forecast

    9.3.2.1.1.  By Value

    9.3.2.2.  Market Share & Forecast

    9.3.2.2.1.  By Livestock

    9.3.2.2.2.  By Additive

    9.3.2.2.3.  By Form

    9.3.2.2.4.  By Source

    9.3.3.    South Africa Animal Intestinal Health Market Outlook

    9.3.3.1.  Market Size & Forecast

    9.3.3.1.1.  By Value

    9.3.3.2.  Market Share & Forecast

    9.3.3.2.1.  By Livestock

    9.3.3.2.2.  By Additive

    9.3.3.2.3.  By Form

    9.3.3.2.4.  By Source

    10.    South America Animal Intestinal Health Market Outlook

    10.1.  Market Size & Forecast

    10.1.1.  By Value

    10.2.  Market Share & Forecast

    10.2.1.  By Livestock

    10.2.2.  By Additive

    10.2.3.  By Form

    10.2.4.  By Source

    10.2.5.  By Country

    10.3.    South America: Country Analysis

    10.3.1.    Brazil Animal Intestinal Health Market Outlook

    10.3.1.1.  Market Size & Forecast

    10.3.1.1.1.  By Value

    10.3.1.2.  Market Share & Forecast

    10.3.1.2.1.  By Livestock

    10.3.1.2.2.  By Additive

    10.3.1.2.3.  By Form

    10.3.1.2.4.  By Source

    10.3.2.    Colombia Animal Intestinal Health Market Outlook

    10.3.2.1.  Market Size & Forecast

    10.3.2.1.1.  By Value

    10.3.2.2.  Market Share & Forecast

    10.3.2.2.1.  By Livestock

    10.3.2.2.2.  By Additive

    10.3.2.2.3.  By Form

    10.3.2.2.4.  By Source

    10.3.3.    Argentina Animal Intestinal Health Market Outlook

    10.3.3.1.  Market Size & Forecast

    10.3.3.1.1.  By Value

    10.3.3.2.  Market Share & Forecast

    10.3.3.2.1.  By Livestock

    10.3.3.2.2.  By Additive

    10.3.3.2.3.  By Form

    10.3.3.2.4.  By Source

    11.    Market Dynamics

    11.1.  Drivers

    11.2.  Challenges

    12.    Market Trends & Developments

    12.1.  Merger & Acquisition (If Any)

    12.2.  Product Launches (If Any)

    12.3.  Recent Developments

    13.    Global Animal Intestinal Health Market: SWOT Analysis

    14.    Porter's Five Forces Analysis

    14.1.  Competition in the Industry

    14.2.  Potential of New Entrants

    14.3.  Power of Suppliers

    14.4.  Power of Customers

    14.5.  Threat of Substitute Products

    15.    Competitive Landscape

    15.1.  AB Agri Limited

    15.1.1.  Business Overview

    15.1.2.  Products & Services

    15.1.3.  Recent Developments

    15.1.4.  Key Personnel

    15.1.5.  SWOT Analysis

    15.2.  Cargill, Incorporated

    15.3.  Calpis Co., Ltd.

    15.4.  Chr. Hansen A/S

    15.5.  Dr. Eckel Animal Nutrition GmbH & Co. KG

    15.6.  Evonik Industries AG

    15.7.  Kemin Industries, Inc.

    15.8.  Koninklijke DSM N.V.

    15.9.  Lallemand Inc.

    16.    Strategic Recommendations

    17.    About Us & Disclaimer

    Figures and Tables

    Frequently asked questions

    Frequently asked questions

    The market size of the Global Animal Intestinal Health Market was estimated to be USD 4.10 Billion in 2024.

    North America is the dominating region in the Global Animal Intestinal Health Market.

    Poultry segment is the fastest growing segment in the Global Animal Intestinal Health Market.

    The Global Animal Intestinal Health Market is expected to grow at 8.00% between 2025 to 2030.

    Related Reports

    We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.